CDMO – Contract manufacturing

TBD Pharmatech’s Välja facility, fully operational and EU-GMP-licensed by Q4 2025, gives clients a dedicated home for commercial API production once development is complete or an established process is transferred in. The 3 000 m² plant in Tartu houses ten purpose-built GMP suites equipped with 50–1 000 L glass-lined and stainless-steel reactors, integrated isolation and drying trains, and segregated personnel and material flows for contamination-free output. Designed for both complex chemistries and high-volume campaigns, Välja secures an EU-based supply chain today while offering expansion headroom for tomorrow. Whether scaling a route from our Tiigi labs or receiving a tech-transfer package, we can carry out routine cGMP manufacturing, validation, and batch release under one streamlined quality system—providing predictable lead times, lot-to-lot consistency, and clear oversight for every project.

Facilities